Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #51 to #550.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 45‏‎ (1 revision)
  2. Intake‏‎ (1 revision)
  3. ICRP Publication 6‏‎ (1 revision)
  4. ICRP Publication 60‏‎ (1 revision)
  5. Dose modifying factor‏‎ (1 revision)
  6. Stem cell‏‎ (1 revision)
  7. Kerma approximation‏‎ (1 revision)
  8. ICRP Publication 75‏‎ (1 revision)
  9. ICRP Publication 9‏‎ (1 revision)
  10. 1934 Recommendations‏‎ (1 revision)
  11. National radon survey‏‎ (1 revision)
  12. Access control‏‎ (1 revision)
  13. General Information: Radon‏‎ (1 revision - redirect page)
  14. Potential alpha energy concentration‏‎ (1 revision)
  15. ICRP Publication 108‏‎ (1 revision)
  16. Brachytherapy‏‎ (1 revision)
  17. ICRP Publication 121‏‎ (1 revision)
  18. Case–control study‏‎ (1 revision)
  19. ICRP Publication 136‏‎ (1 revision)
  20. Collective dose‏‎ (1 revision)
  21. Redox‏‎ (1 revision)
  22. ICRP Publication 150‏‎ (1 revision)
  23. ICRP Publication 25‏‎ (1 revision)
  24. ICRP Publication 97‏‎ (1 revision)
  25. ICRP Publication 31‏‎ (1 revision)
  26. Deterministic effect‏‎ (1 revision)
  27. Secretory cells‏‎ (1 revision)
  28. ICRP Publication 46‏‎ (1 revision)
  29. Intensity-modulated radiotherapy‏‎ (1 revision)
  30. ICRP Publication 61‏‎ (1 revision)
  31. ICRP Publication 76‏‎ (1 revision)
  32. Targeted effects‏‎ (1 revision)
  33. Equilibrium equivalent concentration‏‎ (1 revision)
  34. Expanded radiation field‏‎ (1 revision)
  35. 1937 Recommendations‏‎ (1 revision)
  36. Typical value‏‎ (1 revision)
  37. Adventitious source‏‎ (1 revision)
  38. Particle transport‏‎ (1 revision)
  39. Annual intake‏‎ (1 revision)
  40. ICRP Publication 109‏‎ (1 revision)
  41. ICRP Publication 122‏‎ (1 revision)
  42. ICRP Publication 137‏‎ (1 revision)
  43. ICRP Publication 151‏‎ (1 revision)
  44. Relative biological effectiveness‏‎ (1 revision)
  45. ICRP Publication 26‏‎ (1 revision)
  46. DS86‏‎ (1 revision)
  47. ICRP Publication 98‏‎ (1 revision)
  48. ICRP Publication 32‏‎ (1 revision)
  49. ICRP Publication 47‏‎ (1 revision)
  50. Somatic effect‏‎ (1 revision)
  51. ICRP Publication 62‏‎ (1 revision)
  52. Stochastic effect‏‎ (1 revision)
  53. ICRP Publication 77‏‎ (1 revision)
  54. Equilibrium factor‏‎ (1 revision)
  55. Tolerance dose‏‎ (1 revision)
  56. 1950 Recommendations‏‎ (1 revision)
  57. Occupancy factor‏‎ (1 revision)
  58. Backscatter factor‏‎ (1 revision)
  59. ICRP Publication 10A‏‎ (1 revision)
  60. ICRP Publication 123‏‎ (1 revision)
  61. Charged-particle equilibrium‏‎ (1 revision)
  62. Radon-prone area‏‎ (1 revision)
  63. ICRP Publication 138‏‎ (1 revision)
  64. Collimation‏‎ (1 revision)
  65. Reference Person‏‎ (1 revision)
  66. ICRP Publication 152‏‎ (1 revision)
  67. Relative life lost‏‎ (1 revision)
  68. ICRP Publication 27‏‎ (1 revision)
  69. ICRP Publication 99‏‎ (1 revision)
  70. ICRP Publication 33‏‎ (1 revision)
  71. Detriment-adjusted risk‏‎ (1 revision)
  72. Security screening‏‎ (1 revision)
  73. ICRP Publication 48‏‎ (1 revision)
  74. Dose-response function‏‎ (1 revision)
  75. International Commission on Radiological Protection‏‎ (1 revision)
  76. ICRP Publication 63‏‎ (1 revision)
  77. Lag‏‎ (1 revision)
  78. ICRP Publication 78‏‎ (1 revision)
  79. Elemental dose‏‎ (1 revision)
  80. Teratocarcinoma‏‎ (1 revision)
  81. Low dose‏‎ (1 revision)
  82. Exposed individuals‏‎ (1 revision)
  83. 1954 Recommendations‏‎ (1 revision)
  84. Apoptosis‏‎ (1 revision)
  85. Potentially lethal damage repair‏‎ (1 revision)
  86. ICRP Publication 11‏‎ (1 revision)
  87. ICRP Publication 124‏‎ (1 revision)
  88. ICRP Publication 139‏‎ (1 revision)
  89. ICRP Publication 153‏‎ (1 revision)
  90. Relative risk‏‎ (1 revision)
  91. ICRP Publication 28‏‎ (1 revision)
  92. Ring chromosome‏‎ (1 revision)
  93. ICRP Supporting Guidance 2‏‎ (1 revision)
  94. ICRP Publication 34‏‎ (1 revision)
  95. ICRP Publication 49‏‎ (1 revision)
  96. Source region‏‎ (1 revision)
  97. ICRP Publication 64‏‎ (1 revision)
  98. Late normal tissue responses‏‎ (1 revision)
  99. ICRP Publication 79‏‎ (1 revision)
  100. 1956 Recommendations‏‎ (1 revision)
  101. Activation‏‎ (1 revision)
  102. Α/β value‏‎ (1 revision)
  103. Oncogene‏‎ (1 revision)
  104. ICRP Publication 1‏‎ (1 revision)
  105. Baseline disease rates‏‎ (1 revision)
  106. ICRP Publication 110‏‎ (1 revision)
  107. Breakpoint cluster region/abelson‏‎ (1 revision)
  108. ICRP Publication 125‏‎ (1 revision)
  109. ICRP Publication 14‏‎ (1 revision)
  110. Commissioning‏‎ (1 revision)
  111. ICRP Publication 154‏‎ (1 revision)
  112. Cosmic radiation‏‎ (1 revision)
  113. Relative survival‏‎ (1 revision)
  114. ICRP Publication 29‏‎ (1 revision)
  115. ICRP Publication 35‏‎ (1 revision)
  116. ICRP Publication 5‏‎ (1 revision)
  117. Dose-threshold hypothesis‏‎ (1 revision)
  118. Intervention‏‎ (1 revision)
  119. ICRP Publication 65‏‎ (1 revision)
  120. Sublethal damage repair‏‎ (1 revision)
  121. ICRP Publication 8‏‎ (1 revision)
  122. Transfer of risk‏‎ (1 revision)
  123. Molecular imaging‏‎ (1 revision)
  124. 1959 Decisions‏‎ (1 revision)
  125. Noise‏‎ (1 revision)
  126. ΓH2AX foci‏‎ (1 revision)
  127. Operating management‏‎ (1 revision)
  128. Pencil beam‏‎ (1 revision)
  129. Hereditary effect‏‎ (1 revision)
  130. Practice‏‎ (1 revision)
  131. ICRP Publication 10‏‎ (1 revision)
  132. ICRP Publication 111‏‎ (1 revision)
  133. ICRP Publication 126‏‎ (1 revision)
  134. ICRP Publication 140‏‎ (1 revision)
  135. ICRP Publication 155‏‎ (1 revision)
  136. ICRP Publication 3‏‎ (1 revision)
  137. ICRP Publication 36‏‎ (1 revision)
  138. Dicentric chromosome‏‎ (1 revision)
  139. Severe deterministic injury‏‎ (1 revision)
  140. ICRP Publication 50‏‎ (1 revision)
  141. Dose and dose-rate effectiveness factor‏‎ (1 revision)
  142. ICRP Publication 66‏‎ (1 revision)
  143. Licensee‏‎ (1 revision)
  144. ICRP Publication 80‏‎ (1 revision)
  145. Thermodynamic diameter‏‎ (1 revision)
  146. Low linear energy transfer radiation‏‎ (1 revision)
  147. Nominal risk coefficient‏‎ (1 revision)
  148. Active detection system‏‎ (1 revision)
  149. ICRP Publication 100‏‎ (1 revision)
  150. Quality control testing‏‎ (1 revision)
  151. ICRP Publication 112‏‎ (1 revision)
  152. Radioactive waste‏‎ (1 revision)
  153. ICRP Publication 127‏‎ (1 revision)
  154. ICRP Publication 141‏‎ (1 revision)
  155. ICRP Publication 16‏‎ (1 revision)
  156. ICRP Publication 30‏‎ (1 revision)
  157. Dental and maxillofacial imaging‏‎ (1 revision)
  158. Risk model‏‎ (1 revision)
  159. ICRP Publication 37‏‎ (1 revision)
  160. Sheltering‏‎ (1 revision)
  161. Induced genomic instability‏‎ (1 revision)
  162. ICRP Publication 51‏‎ (1 revision)
  163. ICRP Publication 67‏‎ (1 revision)
  164. Doubling dose‏‎ (1 revision)
  165. Superposition principle‏‎ (1 revision)
  166. Life Span Study‏‎ (1 revision)
  167. ICRP Publication 81‏‎ (1 revision)
  168. Thoracic airways‏‎ (1 revision)
  169. Evacuation‏‎ (1 revision)
  170. Multifactorial diseases‏‎ (1 revision)
  171. Exposure index‏‎ (1 revision)
  172. AML/eto‏‎ (1 revision)
  173. Nominal value‏‎ (1 revision)
  174. Frequent flyer‏‎ (1 revision)
  175. Attributable risk‏‎ (1 revision)
  176. ICRP Publication 101‏‎ (1 revision)
  177. Best available techniques‏‎ (1 revision)
  178. ICRP Publication 113‏‎ (1 revision)
  179. Bronchiolar region‏‎ (1 revision)
  180. ICRP Publication 128‏‎ (1 revision)
  181. ICRP Publication 142‏‎ (1 revision)
  182. Compartment‏‎ (1 revision)
  183. ICRP Publication 17‏‎ (1 revision)
  184. Count median diameter‏‎ (1 revision)
  185. ICRP Publication 30 (Index)‏‎ (1 revision)
  186. ICRPædia Guide to Radiological Protection in Healthcare‏‎ (1 revision - redirect page)
  187. ICRP Publication 38‏‎ (1 revision)
  188. Shielding‏‎ (1 revision)
  189. ICRP Publication 52‏‎ (1 revision)
  190. Dose commitment‏‎ (1 revision)
  191. ICRP Publication 68‏‎ (1 revision)
  192. Supervised area‏‎ (1 revision)
  193. ICRP Publication 82‏‎ (1 revision)
  194. Thoron progeny‏‎ (1 revision)
  195. Excess absolute risk‏‎ (1 revision)
  196. Transgenerational effect‏‎ (1 revision)
  197. Exposure pathway‏‎ (1 revision)
  198. Non-homologous end joining‏‎ (1 revision)
  199. Functional subunits‏‎ (1 revision)
  200. Activity median aerodynamic diameter‏‎ (1 revision)
  201. Optimisation of protection‏‎ (1 revision)
  202. Ground-level enhancement‏‎ (1 revision)
  203. ICRP Publication 101a‏‎ (1 revision)
  204. Quasi-threshold dose‏‎ (1 revision)
  205. ICRP Publication 114‏‎ (1 revision)
  206. ICRP Publication 129‏‎ (1 revision)
  207. Radon progeny‏‎ (1 revision)
  208. ICRP Publication 143‏‎ (1 revision)
  209. Compartment (environmental)‏‎ (1 revision)
  210. Reference parameter value‏‎ (1 revision)
  211. ICRP Publication 18‏‎ (1 revision)
  212. Cross section‏‎ (1 revision)
  213. ICRP Publication 30 (Part 1)‏‎ (1 revision)
  214. Deposition‏‎ (1 revision)
  215. ICRP Publication 39‏‎ (1 revision)
  216. Digital breast tomosynthesis‏‎ (1 revision)
  217. ICRP Publication 53‏‎ (1 revision)
  218. Specific absorbed fraction‏‎ (1 revision)
  219. ICRP Publication 69‏‎ (1 revision)
  220. Surface contamination‏‎ (1 revision)
  221. ICRP Publication 83‏‎ (1 revision)
  222. Translocation‏‎ (1 revision)
  223. Multistage carcinogenesis model‏‎ (1 revision)
  224. Phantom‏‎ (1 revision)
  225. Homologous recombination‏‎ (1 revision)
  226. Authorised discharge‏‎ (1 revision)
  227. ICRP Publication 101b‏‎ (1 revision)
  228. ICRP Publication 115‏‎ (1 revision)
  229. ICRP Publication 13‏‎ (1 revision)
  230. Clinical audit‏‎ (1 revision)
  231. Ras‏‎ (1 revision)
  232. ICRP Publication 144‏‎ (1 revision)
  233. Reference phantom‏‎ (1 revision)
  234. ICRP Publication 19‏‎ (1 revision)
  235. ICRP Publication 90‏‎ (1 revision)
  236. ICRP Publication 30 (Part 2)‏‎ (1 revision)
  237. ICRP Publication 4‏‎ (1 revision)
  238. Size-specific dose estimate‏‎ (1 revision)
  239. ICRP Publication 54‏‎ (1 revision)
  240. ICRP Publication 7‏‎ (1 revision)
  241. ICRP Publication 84‏‎ (1 revision)
  242. Threshold level‏‎ (1 revision)
  243. Exclusion‏‎ (1 revision)
  244. Acute exposure‏‎ (1 revision)
  245. Organ at risk‏‎ (1 revision)
  246. Allometry‏‎ (1 revision)
  247. Principles of protection‏‎ (1 revision)
  248. ICRP Publication 102‏‎ (1 revision)
  249. Radiation-induced second cancer‏‎ (1 revision)
  250. ICRP Publication 116‏‎ (1 revision)
  251. ICRP Publication 130‏‎ (1 revision)
  252. Rb‏‎ (1 revision)
  253. ICRP Publication 145‏‎ (1 revision)
  254. Reference value‏‎ (1 revision)
  255. ICRP Publication 2‏‎ (1 revision)
  256. ICRP Publication 91‏‎ (1 revision)
  257. ICRP Publication 30 (Part 3)‏‎ (1 revision)
  258. Derived consideration reference level‏‎ (1 revision)
  259. ICRP Publication 40‏‎ (1 revision)
  260. Slice‏‎ (1 revision)
  261. ICRP Publication 55‏‎ (1 revision)
  262. Dose conversion convention‏‎ (1 revision)
  263. Spongiosa‏‎ (1 revision)
  264. ICRP Publication 70‏‎ (1 revision)
  265. Effect modifier‏‎ (1 revision)
  266. ICRP Publication 85‏‎ (1 revision)
  267. Endosteum‏‎ (1 revision)
  268. Marrow cellularity‏‎ (1 revision)
  269. Multitarget equation‏‎ (1 revision)
  270. Pilomatricoma‏‎ (1 revision)
  271. Biological half-life‏‎ (1 revision)
  272. Radiation-induced secondary malignancy‏‎ (1 revision)
  273. ICRP Publication 117‏‎ (1 revision)
  274. Radiological attack‏‎ (1 revision)
  275. ICRP Publication 131‏‎ (1 revision)
  276. Reactive oxygen species‏‎ (1 revision)
  277. ICRP Publication 146‏‎ (1 revision)
  278. Concentration ratio‏‎ (1 revision)
  279. Reference worker‏‎ (1 revision)
  280. ICRP Publication 20‏‎ (1 revision)
  281. ICRP Publication 92‏‎ (1 revision)
  282. ICRP Publication 30 (Part 4)‏‎ (1 revision)
  283. Derived investigation level‏‎ (1 revision)
  284. ICRP Publication 41‏‎ (1 revision)
  285. Directional dose equivalent‏‎ (1 revision)
  286. Informed consent‏‎ (1 revision)
  287. ICRP Publication 56‏‎ (1 revision)
  288. Dose conversion factor‏‎ (1 revision)
  289. ICRP Publication 71‏‎ (1 revision)
  290. System of radiological protection‏‎ (1 revision)
  291. ICRP Publication 86‏‎ (1 revision)
  292. Time-resolved computed tomography‏‎ (1 revision)
  293. Mutation component‏‎ (1 revision)
  294. Waste management‏‎ (1 revision)
  295. Normal tissue complication probability‏‎ (1 revision)
  296. Human Alimentary Tract Model‏‎ (1 revision)
  297. ICRP Publication 104‏‎ (1 revision)
  298. Biomarker‏‎ (1 revision)
  299. Radiological controlled area‏‎ (1 revision)
  300. ICRP Publication 132‏‎ (1 revision)
  301. Clonogenic surviving fraction‏‎ (1 revision)
  302. ICRP Publication 147‏‎ (1 revision)
  303. Cone beam computed tomography‏‎ (1 revision)
  304. Referrer‏‎ (1 revision)
  305. ICRP Publication 21‏‎ (1 revision)
  306. ICRP Publication 93‏‎ (1 revision)
  307. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
  308. Derived limit‏‎ (1 revision)
  309. ICRU 4-element tissue‏‎ (1 revision)
  310. ICRP Publication 42‏‎ (1 revision)
  311. ICRP Publication 57‏‎ (1 revision)
  312. ICRP Publication 72‏‎ (1 revision)
  313. ICRP Publication 87‏‎ (1 revision)
  314. Treatment preparation in radiotherapy‏‎ (1 revision)
  315. Absorption Type‏‎ (1 revision - redirect page)
  316. Notification value‏‎ (1 revision)
  317. Additional dose‏‎ (1 revision)
  318. Other (systemic) tissues‏‎ (1 revision)
  319. Ambient dose equivalent‏‎ (1 revision)
  320. Human Respiratory Tract Model‏‎ (1 revision)
  321. Automatic exposure control‏‎ (1 revision)
  322. ICRP Publication 105‏‎ (1 revision)
  323. ICRP Publication 119‏‎ (1 revision)
  324. ICRP Publication 133‏‎ (1 revision)
  325. ICRP Publication 148‏‎ (1 revision)
  326. Region‏‎ (1 revision)
  327. ICRP Publication 22‏‎ (1 revision)
  328. ICRP Publication 94‏‎ (1 revision)
  329. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
  330. Derived reference level‏‎ (1 revision)
  331. ICRU sphere‏‎ (1 revision)
  332. ICRP Publication 43‏‎ (1 revision)
  333. Disposal facility‏‎ (1 revision)
  334. ICRP Publication 58‏‎ (1 revision)
  335. Stakeholder‏‎ (2 revisions)
  336. Effective dose equivalent‏‎ (2 revisions)
  337. Tachycardia‏‎ (2 revisions)
  338. Tissue equivalent material‏‎ (2 revisions)
  339. Existing exposure situation‏‎ (2 revisions)
  340. Myocardial stress test‏‎ (2 revisions)
  341. Gastroschisis‏‎ (2 revisions)
  342. Oversight‏‎ (2 revisions)
  343. Angiogenesis‏‎ (2 revisions)
  344. Hyperbaric oxygen‏‎ (2 revisions)
  345. Projected dose‏‎ (2 revisions)
  346. Bioturbation‏‎ (2 revisions)
  347. Cardioverter-defibrillator‏‎ (2 revisions)
  348. Radionuclides of natural origin‏‎ (2 revisions)
  349. Recovery (cellular or tissue)‏‎ (2 revisions)
  350. Consequential late effects‏‎ (2 revisions)
  351. Retrievability‏‎ (2 revisions)
  352. Immune system‏‎ (2 revisions)
  353. Institutional control‏‎ (2 revisions)
  354. Epithelium‏‎ (2 revisions)
  355. Acceptance test‏‎ (2 revisions)
  356. Worker‏‎ (2 revisions)
  357. Nuclear track detectors‏‎ (2 revisions)
  358. Gastrulation‏‎ (2 revisions)
  359. Habitual mouth breather‏‎ (2 revisions)
  360. Annihilation photons‏‎ (2 revisions)
  361. Hyperfractionation‏‎ (2 revisions)
  362. Bone marrow‏‎ (2 revisions)
  363. Radiation safety officer‏‎ (2 revisions)
  364. Radioresponsiveness‏‎ (2 revisions)
  365. Cohort study‏‎ (2 revisions)
  366. Recovery responder‏‎ (2 revisions)
  367. DRL value‏‎ (2 revisions)
  368. Reversibility‏‎ (2 revisions)
  369. In vivo radiobioassay‏‎ (2 revisions)
  370. Solar particle event‏‎ (2 revisions)
  371. Target tissue‏‎ (2 revisions)
  372. Equieffective dose‏‎ (2 revisions)
  373. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  374. Expanded and aligned radiation field‏‎ (2 revisions)
  375. Working level‏‎ (2 revisions)
  376. OLINDA/EXM‏‎ (2 revisions)
  377. Adventitious‏‎ (2 revisions)
  378. Particle radiance‏‎ (2 revisions)
  379. Habitual nose breather‏‎ (2 revisions)
  380. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  381. Background dose (rate)‏‎ (2 revisions)
  382. Protection strategy‏‎ (2 revisions)
  383. Radiation source‏‎ (2 revisions)
  384. Radiosensitiser‏‎ (2 revisions)
  385. Containment‏‎ (2 revisions)
  386. Rehabilitation of living conditions‏‎ (2 revisions)
  387. Right to know‏‎ (2 revisions)
  388. Incidence‏‎ (2 revisions)
  389. Dose-length product‏‎ (2 revisions)
  390. Solar wind‏‎ (2 revisions)
  391. Stenosis‏‎ (2 revisions)
  392. Electron-capture decay‏‎ (2 revisions)
  393. Local DRL‏‎ (2 revisions)
  394. Tolerability‏‎ (2 revisions)
  395. Medical exposure‏‎ (2 revisions)
  396. Naturally occurring radioactive material‏‎ (2 revisions)
  397. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  398. Working level month‏‎ (2 revisions)
  399. Hypoplasia‏‎ (2 revisions)
  400. Backscatter detection system‏‎ (2 revisions)
  401. Bradycardia‏‎ (2 revisions)
  402. Radiosensitivity, cellular‏‎ (2 revisions)
  403. Rigidity‏‎ (2 revisions)
  404. Detriment‏‎ (2 revisions)
  405. Security‏‎ (2 revisions)
  406. Incident‏‎ (2 revisions)
  407. Dose-rate effect‏‎ (2 revisions)
  408. Intermediate level waste‏‎ (2 revisions)
  409. Dose of record Hp (10)‏‎ (2 revisions)
  410. LD 50/30‏‎ (2 revisions)
  411. Electrophysiology‏‎ (2 revisions)
  412. Telangiectasia‏‎ (2 revisions)
  413. Member of the public‏‎ (2 revisions)
  414. Unattached fraction‏‎ (2 revisions)
  415. Necrosis‏‎ (2 revisions)
  416. Accreditation‏‎ (2 revisions)
  417. Genomic integrity‏‎ (2 revisions)
  418. Patient entrance reference point‏‎ (2 revisions)
  419. Hazard‏‎ (2 revisions)
  420. Potential recoverability correction factor‏‎ (2 revisions)
  421. Protective action guide‏‎ (2 revisions)
  422. Bragg peak‏‎ (2 revisions)
  423. Radiation worker‏‎ (2 revisions)
  424. Coronary heart disease‏‎ (2 revisions)
  425. Decay constant‏‎ (2 revisions)
  426. Inclusiveness‏‎ (2 revisions)
  427. Source-related‏‎ (2 revisions)
  428. Internal conversion electron‏‎ (2 revisions)
  429. Storage‏‎ (2 revisions)
  430. Track structure‏‎ (2 revisions)
  431. Mendelian diseases‏‎ (2 revisions)
  432. Neurological syndrome‏‎ (2 revisions)
  433. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  434. Action Level‏‎ (2 revisions)
  435. Occupational exposure‏‎ (2 revisions)
  436. Peak skin dose‏‎ (2 revisions)
  437. Health Surveillance‏‎ (2 revisions)
  438. Basal cell‏‎ (2 revisions)
  439. Branching fraction‏‎ (2 revisions)
  440. Radioactive dispersion device‏‎ (2 revisions)
  441. Chronic exposure‏‎ (2 revisions)
  442. Radon: Units of Measure‏‎ (2 revisions)
  443. Colony‏‎ (2 revisions)
  444. Reference air kerma‏‎ (2 revisions)
  445. Cosmic Radiation in Aviation‏‎ (2 revisions)
  446. Decommissioning‏‎ (2 revisions)
  447. Self-help protection‏‎ (2 revisions)
  448. Individual-related‏‎ (2 revisions)
  449. Dose-threshold‏‎ (2 revisions)
  450. Dose per unit intake coefficient‏‎ (2 revisions)
  451. Subcutaneous tissue‏‎ (2 revisions)
  452. Emergency‏‎ (2 revisions)
  453. Low dose rate‏‎ (2 revisions)
  454. Transfer compartment‏‎ (2 revisions)
  455. Mitigation‏‎ (2 revisions)
  456. Exposure, external or internal‏‎ (2 revisions)
  457. Upper reference levels‏‎ (2 revisions)
  458. Neurovascular syndrome‏‎ (2 revisions)
  459. Graft vs host disease‏‎ (2 revisions)
  460. Air-kerma, incident‏‎ (2 revisions)
  461. Pelagic‏‎ (2 revisions)
  462. Heliosphere‏‎ (2 revisions)
  463. Practical radiological protection culture‏‎ (2 revisions)
  464. Radioactive source‏‎ (2 revisions)
  465. Class SR-0 gases‏‎ (2 revisions)
  466. Decontamination‏‎ (2 revisions)
  467. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  468. Diastasis‏‎ (2 revisions)
  469. Individual decontamination‏‎ (2 revisions)
  470. Source term‏‎ (2 revisions)
  471. Dose rate‏‎ (2 revisions)
  472. Latent time/period or latency interval‏‎ (2 revisions)
  473. Emergency exposure situation‏‎ (2 revisions)
  474. Low level waste‏‎ (2 revisions)
  475. Erythropoietin‏‎ (2 revisions)
  476. Exposure (in the context of inhalation)‏‎ (2 revisions)
  477. Fractionation and dose delivery patterns‏‎ (2 revisions)
  478. Qualified expert‏‎ (2 revisions)
  479. Broad beam therapy irradiation technique‏‎ (2 revisions)
  480. Radioactive substance‏‎ (2 revisions)
  481. Class SR-1 gases‏‎ (2 revisions)
  482. Committed effective dose‏‎ (2 revisions)
  483. Reference biokinetic model‏‎ (2 revisions)
  484. Cost-benefit analysis‏‎ (2 revisions)
  485. Relocation‏‎ (2 revisions)
  486. Decontamination factor‏‎ (2 revisions)
  487. Risk coefficient‏‎ (2 revisions)
  488. Individual monitoring‏‎ (2 revisions)
  489. Intervention Level‏‎ (2 revisions)
  490. Dose rate effectiveness factor‏‎ (2 revisions)
  491. Substantial radiation dose level‏‎ (2 revisions)
  492. Emergency plan‏‎ (2 revisions)
  493. Ethics‏‎ (2 revisions)
  494. Transfer rate‏‎ (2 revisions)
  495. Multi-detector computed tomography‏‎ (2 revisions)
  496. ALARA‏‎ (2 revisions)
  497. Percutaneous coronary intervention‏‎ (2 revisions)
  498. Hierarchical tissues‏‎ (2 revisions)
  499. Area monitoring‏‎ (2 revisions)
  500. Prevailing circumstances‏‎ (2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)